From leading role to the backstage: Mesenchymal stem cells as packaging cell lines for in situ production of viral vectors

Medical Hypotheses

Volumn 67, Issue 4, 2006, Pages 922-925

  Silva, F H ^a   Nardi, N B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CELL ISOLATION; CELL LINE; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; MESENCHYME CELL; MICROENVIRONMENT; NONHUMAN; PACKAGING CELL LINE; PLASMID; PRIORITY JOURNAL; SOLID TUMOR; TARGET CELL; TUMOR CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS ASSEMBLY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CELL LINE; DNA, VIRAL; GENE THERAPY; GENETIC VECTORS; HUMANS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; RETROVIRIDAE; RNA, VIRAL; VIRUS ASSEMBLY;

EID: 33745938578     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.01.065     Document Type: Article

References (25)

1. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high titer helper-free retroviruses by transient transfection. PNAS 90 (1993) 8392-8396
2. Pagès J.C., and Bru T. Toolbox for retrovectorologists. J Gene Med 6 (2004) S67-S82
3. Merten O.-W. State-of-the-art of the production of retroviral vectors. J Gene Med 6 (2004) S105-S124
4. Delenda C. Lentiviral vectors: optimisation of packaging, transduction and gene expression. J Gene Med 6 (2004) S125-S138
5. Verhoeyen E., and Cosset F.-L. Surface engineering of lentiviral vectors. J Gene Med 6 (2004) S83-S94
6. Meirelles L.S., and Nardi N.B. Murine marrow-derived mesenchymal stem cells: isolation, in vitro expansion and characterization. Brit J Hematol 123 (2003) 702-711
7. Nardi N.B., and Meirelles L.S. Mesenchymal stem cells: isolation, in vitro expansion and characterization. In: Wobus A.M., and Boheler K.R. (Eds). Handbook of experimental pharmacology (2006), Springer, Berlin/Heidelberg 249-282
8. Naldini L., Blömer U., Gallay P., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
9. Ory D.S., Neugeboren B.A., and Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. PNAS 93 (1996) 11400-11406
10. Kaplan A.H., and Swanstrom R. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. PNAS 88 (1991) 4528-4532
11. Xu K., Marina H., McCown T.J., Verma I.M., and Kafri T. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther 3 (1997) 97-104
12. Newbound G.C., Cooper J.R., O'Rourke J.P., Baskin C.R., and Bunnel B. Analysis of gene transfer efficiency of retrovirus producer cell transplantation for in situ gene transfer to hematopoietic cells. Exp Hematol 29 (2001) 163-173
13. Wang W.J., Tai C.K., Kasahara N., and Chen T.C. Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors. Hum Gene Ther 14 (2003) 117-127
14. http://www.wiley.co.uk/genmed/clinical/, trial ID: US-099, November 2005.
15. Nakamizo A., Marini F., Amano T., et al. Human bone-marrow derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65 (2005) 3307-3318
16. Shah K., Bureau E., Kim D.E., et al. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 57 (2005) 34-41
17. Chan J., O'Donoghue K., Fuente J., et al. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23 (2004) 93-102
18. Potapova I., Plotnikov A., Lu Z., et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res 94 (2004) 952-959
19. Yoshikawa T., Uchimura E., Kishi M., Funeriu D.P., Miyake M., and Miyake J. Transfection microarray of human mesenchymal stem cells and on-chip siRNA gene knockdown. J Control Release 96 (2004) 227-232
20. Sastry L., Xu Y., Johnson T., et al. Certification assays for HIV-1 based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol Ther 8 (2003) 830-839
21. Wang Y., Hu J.K., Krol A., Li Y.-P., Li C.-Y., and Yuan F. Systemic dissemination of viral vectors during intratumoral injection. Mol Cancer Ther 2 (2003) 1233-1242
22. Blömer U., Gruh I., Witschel H., Haverich A., and Martin U. Shuttle of lentiviral vectors via transplanted cells in vivo. Gene Ther 12 (2005) 67-74
23. Patience C., Takeuchi Y., Cosset F.-L., and Weiss R.A. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells. J Virol 72 (1998) 2671-2676
24. Chong H., Starkey W., and Vile R.G. A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs and endogenous retroviral sequences. J Virol 72 (1998) 2663-2670
25. Swanstrom R., and Wills J.W. Retroviral gene expression: synthesis, assembly and processing of viral protein. In: Varmus H.E., Coffin J.M., and Hughes S.H. (Eds). Retroviruses (1997), Cold Spring Harbour Laboratory Press, EUA 263-334